Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Flutamide and its metabolite can effectively reduce androgen effects.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Oral bicalutamide is safe and effective for female hair loss.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

CTP-543 is generally safe for treating alopecia areata.